Doctors Aim to Loosen Anemia Drug Limits
September 1, 2007 By MATTHEW PERRONE, AP Business Writer(AP) -- Cancer doctors seek to loosen federal restrictions on anemia drugs that carry potentially deadly side effects, saying the tight payment guidelines for treatments made by Amgen and Johnson and Johnson are ultimately bad for patients.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .
Similar stories from PHYSorg:
Anemia drugs under scrutiny
Mar 13, 2008 |
5 / 5 (1) |
0
Study finds stroke risk from anemia drug Aranesp
Oct 31, 2009 |
4 / 5 (1) |
0
FDA: Arthritis drugs pose cancer risk to children
Aug 04, 2009 |
not rated yet |
1
Study: Heart failure drug guidelines often ignored
Oct 20, 2009 |
5 / 5 (2) |
0
FDA weighs approval of psychiatric drugs for kids
Jun 05, 2009 |
3 / 5 (2) |
3


